购物车
- 全部删除
- 您的购物车当前为空
CM-579 trihydrochloride is a first-in-class reversible and dual inhibitor of G9a and DNMT (IC50s: 16 nM, 32 nM) with potent in vitro cellular activity in a wide range of cancer cells.
CM-579 trihydrochloride is a first-in-class reversible and dual inhibitor of G9a and DNMT (IC50s: 16 nM, 32 nM) with potent in vitro cellular activity in a wide range of cancer cells.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 8-10周 | |
50 mg | ¥ 13,800 | 8-10周 | |
100 mg | ¥ 17,500 | 8-10周 |
产品描述 | CM-579 trihydrochloride is a first-in-class reversible and dual inhibitor of G9a and DNMT (IC50s: 16 nM, 32 nM) with potent in vitro cellular activity in a wide range of cancer cells. |
靶点活性 | DNA methyltransferase:32 nM, DNMT1:1.5 nM (kd), DNMT3B:1000 nM, G9a:16 nM, DNMT3A:92 nM |
体外活性 | The Kd of CM-579 for DNMT1 is 1.5 nM, CM-579 also inhibits DNMT3A and DNMT3B (IC50s: 92 nM and 1000 nM). |
别名 | CM-579 trihydrochloride |
分子量 | 602.04 |
分子式 | C29H43Cl3N4O3 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: 37.5 mg/mL (62.29 mM), Sonication is recommended. DMSO: 125 mg/mL (207.63 mM), Sonication is recommended. MEthanol: 75 mg/mL (124.58 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/MEthanol/DMSO
MEthanol/DMSO
|
评论内容